Active Not Recruiting PHASE2 INTERVENTIONAL 2-arm NCT05135663

Extension Study of NS-089/NCNP-02 in DMD

A Phase II, Open-Label, Extension Study of NS-089/NCNP-02 in Patients With Duchenne Muscular Dystrophy

Sponsor: Nippon Shinyaku Co., Ltd.

Conditions Duchenne Muscular Dystrophy (DMD)

Updated 6 times since 2021 Last updated: Jul 16, 2025 Started: Jun 23, 2021 Primary completion: Apr 30, 2027 Completion: Apr 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05135663, this PHASE2 trial focuses on Duchenne Muscular Dystrophy (DMD) and remains ongoing. Sponsored by Nippon Shinyaku Co., Ltd., it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Aug 2025 — Present [monthly]

Active Not Recruiting PHASE2
Dec 2024 — Aug 2025 [monthly]

Active Not Recruiting PHASE2
Sep 2024 — Dec 2024 [monthly]

Active Not Recruiting PHASE2
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting PHASE2
Apr 2023 — Jul 2024 [monthly]

Active Not Recruiting PHASE2

▶ Show 1 earlier version

Dec 2021 — Apr 2023 [monthly]

Active Not Recruiting PHASE2

First recorded

Jun 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nippon Shinyaku Co., Ltd.

Data source: Nippon Shinyaku Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kagoshima, Japan
• Tokyo, Japan